51. Long-term alterations in somatosensory functioning in survivors of childhood cancer
- Author
-
Melanie Noel, Simon B. Sherry, Laura Cornelissen, Javeria A. Hashmi, Sitara de Gagne, Jennifer Stinson, Perri R. Tutelman, Sherry H. Stewart, Gregory M.T. Guilcher, Conrad V. Fernandez, Maya Stern, Christine T. Chambers, Robin Urquhart, Lauren C. Heathcote, Julia MacLeod, Annette Flanders, and Fiona Schulte
- Subjects
Male ,Pain Threshold ,Vincristine ,medicine.medical_specialty ,Sensory processing ,medicine.medical_treatment ,Population ,Pain ,Cancer Survivors ,Internal medicine ,Neoplasms ,Medicine ,Humans ,Survivors ,education ,Child ,education.field_of_study ,Leukemia ,business.industry ,Cumulative dose ,Cancer ,medicine.disease ,Anesthesiology and Pain Medicine ,Neurology ,Anxiety ,Pain catastrophizing ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Psychosocial ,medicine.drug - Abstract
Cancer and its treatment can have lasting consequences on somatosensation, including pain, which is often underrecognized and undertreated. Research characterizing the impact of cancer on pain and sensory processing in survivors of childhood cancer is scarce. This study aimed to quantify generalized differences in pain and sensory processing in survivors of childhood cancer compared with reference data using a standardized thermal and mechanical quantitative sensory testing (QST) protocol. The association between demographic, clinical (eg, leukemia vs other cancers and treatment exposures), and psychosocial (eg, anxiety and pain catastrophizing) variables and sensitivity to pain and sensory stimuli were also evaluated. Participants were 56 survivors of various types of childhood cancer (52% male, Mage = 13.5 years, SD = 3.2, range = 8-17 years). On average, children were 7 years (SD = 4.1, range = 1.2-16.5) post treatment. Almost all participants (86%) had at least 1 abnormal QST parameter compared with age- and sex-matched reference data; however, few participants self-reported the presence of sensory abnormalities. Generally, participants exhibited reduced sensitivity across the QST parameters examined (Ps < 0.05, ds = 0.40-3.45). A significant minority (45%) also exhibited pain sensitization (P
- Published
- 2021